ADGM — Adagio Medical Holdings Income Statement
0.000.00%
Last trade - 00:00- $20.00m
- $15.49m
- $0.60m
Annual income statement for Adagio Medical Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.27 | 0.189 | 0.3 | 0.602 |
| Cost of Revenue | ||||
| Gross Profit | -0.888 | -0.686 | -1.01 | -2.72 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 20.9 | 24.1 | 28.2 | 84.8 |
| Operating Profit | -20.6 | -23.9 | -27.9 | -84.2 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -19.9 | -23.7 | -36.6 | -75 |
| Net Income After Taxes | -19.9 | -23.7 | -36.6 | -75 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -19.9 | -23.7 | -36.6 | -75 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -19.9 | -23.7 | -36.6 | -75 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -1.49 | -1.77 | -2.73 | -1.7 |